Each year, the United Nations Office on Drugs and Crime publishes the World Drug Report, one of the most comprehensive assessments of drug use and illicit drug markets worldwide. Much of the report focuses on international production, trafficking and policy, but its findings also reveal important changes in the nature of addiction and the needs of the people seeking help.
Although the World Drug Report 2026 was published this year, many of its global estimates cover 2024. That delay is normal for a report of this scale. Data must be gathered from countries around the world, reviewed and standardized before global estimates can be produced.
The latest findings point to an addiction landscape that is growing in both scale and complexity. Synthetic opioids are changing the illicit drug supply. Cocaine and methamphetamine markets continue to expand. Pharmaceutical misuse and polysubstance use are complicating treatment, while tens of millions of people with drug use disorders remain disconnected from care.
For people struggling with addiction and their families, the report reinforces the danger of waiting. For treatment providers, social workers, healthcare professionals and other referral partners, it shows why addiction care must address far more than the substance someone identifies as their primary problem.
The Biggest Problem Is That Most People Never Receive Treatment
An estimated 331 million people used drugs worldwide in 2024, representing an increase of 34 percent over the previous decade. Not everyone who uses a drug develops an addiction, but UNODC estimates that approximately 63 million people were living with drug use disorders. Only 8.2 percent of that population received treatment, meaning roughly 11 out of every 12 people who needed care did not receive it.
The treatment gap is even wider among women. The report estimates that only one in 23 women with a drug use disorder received treatment, compared with approximately one in nine men. Women may face distinct barriers related to stigma, childcare, trauma, financial dependence, unsafe relationships and fear of legal or family consequences. The report also notes that women are more likely to report pain, anxiety, depression and other negative emotional states as reasons for beginning or continuing drug use.
Those figures help correct a common assumption that people remain untreated simply because they do not want recovery. Motivation is part of the picture, but so are practical and emotional barriers. People worry about losing their jobs, leaving their children, paying for care or admitting the extent of the problem. Shame can convince someone that asking for help will expose them as a failure, even when continuing to use is already threatening everything they are trying to protect.
Treatment must be clinically effective, but it must also be accessible. Flexible program schedules, transportation support, insurance guidance, virtual options, case management and connections to stable housing can determine whether a person follows through with a referral. Simply handing someone a list of treatment centers is not always enough. A successful referral may require helping the person make the call, confirming the appropriate level of care and staying involved until they are connected.
Today’s Drug Supply Is Less Predictable Than Ever
The World Drug Report 2026 describes a potential turning point in the global opioid market. For more than a century, heroin has played a dominant role in the illicit opioid supply. That market is now being reshaped by the increased availability of fentanyl, nitazenes and other synthetic opioids, along with a dramatic reduction in opium production in Afghanistan.
UNODC reports that Afghanistan’s illicit opium production fell by approximately 95 percent after 2022. As heroin supplies tighten, traffickers may replace the shortage with cheaper and more potent synthetic substances. North America has already shown how quickly fentanyl can displace heroin, and the report warns that similar shifts could occur elsewhere.
The immediate concern for someone using drugs is not the economics of the global heroin trade. It is that the contents of the product in front of them may be unknown. A substance sold as heroin or a prescription opioid may contain fentanyl, a nitazene or another synthetic opioid with much greater potency. Cocaine, counterfeit pills and other non-opioid drugs may also contain unexpected substances.
The report identified 755 new psychoactive substances in global drug markets during 2024, including 118 reported for the first time. Traditional drugs still account for far more use overall, but certain new substances can carry disproportionate risk. Some fentanyl analogues and nitazenes may be more dangerous than the controlled substances they imitate or replace.
This unpredictability strengthens the case for naloxone access, overdose education and rapid connection to care. It also shows why treatment providers cannot rely only on what a substance was called when it was purchased. Clinical assessment must account for withdrawal symptoms, toxicology results, overdose history, co-occurring substance use and the possibility that the person was exposed to something they never intended to take.
The Era of “One-Drug” Addiction Is Ending
People have always combined substances, but today’s patterns of use are becoming especially difficult to separate into clean categories. Someone may enter treatment describing opioids as the main problem while also using cocaine, alcohol, benzodiazepines or cannabis. Another person may seek help for stimulant use but rely on sedatives to sleep or reduce the effects of a binge. In some cases, the person is intentionally combining substances. In others, the mixture begins further up the supply chain.
The report gives particular attention to the misuse of pharmaceutical drugs. Benzodiazepines are among the most commonly misused medications across regions and frequently appear in polysubstance use. They may be used to manage anxiety, depression, stimulant aftereffects, alcohol-related symptoms or opioid withdrawal. The report also describes overlap between opioid use and the misuse of drugs such as codeine and pregabalin.
These patterns can increase the risk of overdose, complicate withdrawal and obscure the relationship between substance use and mental health symptoms. A person experiencing anxiety, depression, paranoia, hallucinations or severe sleep disruption may have an underlying psychiatric disorder, a drug-induced condition or both. Treatment must be prepared to evaluate that complexity rather than telling the person to resolve one condition before receiving help for the other.
Expanding stimulant markets add another challenge. Cocaine production has increased more than fourfold over the past decade, while methamphetamine markets continue to reach new regions and populations. Stimulant addiction may remain hidden for a long time, particularly when a person is still employed or maintaining some outward responsibilities. Behind that appearance, they may be dealing with mounting anxiety, sleeplessness, financial problems, paranoia and an inability to stop.
There is no single standard medication for cocaine or methamphetamine addiction comparable to medications used in opioid treatment. Recovery may depend heavily on behavioral therapy, psychiatric care, accountability, peer support and long-term engagement. That makes retention in treatment especially important. Stabilizing for a few days may interrupt use, but it rarely addresses the habits, thought patterns, triggers and emotional conditions driving it.
Addiction Affects Families, but Addiction Should Not Be Equated With Violence
The report’s section on safety and security could easily be misread as evidence that people who use drugs are inherently violent or dangerous. UNODC makes a more careful argument. The relationship between substance use and harmful behavior is influenced by the type of drug, the amount and frequency of use, intoxication or withdrawal, mental state, personal history, socioeconomic conditions and the surrounding environment.
The report describes three overlapping pathways through which drug use may affect safety. Intoxication or withdrawal can change perception, judgment and impulse control. Some people commit theft or other offenses to finance dependent drug use. Harm can also emerge from the illegal markets surrounding the sale and use of drugs. At the same time, trauma, poverty, homelessness, poor mental health, unemployment, stigma and limited access to treatment all influence these outcomes. Supportive relationships, stable environments and access to health and social services may serve as protective factors.
In other words, the relationship is probabilistic, not inevitable. Many people who use drugs never become violent. Some are far more likely to be victimized than to harm anyone else.
Families can still experience serious instability as addiction progresses. Money disappears, responsibilities go unmet and trust erodes. Parents, spouses and children may live with repeated uncertainty about whether their loved one is safe, whether they are telling the truth or whether the next crisis will involve an overdose, job loss, arrest or medical emergency.
Family support does not mean pretending these consequences are harmless. It means learning how to respond without enabling, how to set boundaries without abandoning the person and how to protect the well-being of everyone in the home. Family education, counseling and peer support can be valuable parts of the recovery process because addiction rarely affects only the person using substances.
Earlier Treatment Matters More Than Ever
People sometimes delay treatment because they believe they have not reached the point where they “really need” it. They still have a job, a home or a relationship. They have not experienced an overdose. They can stop for several days at a time and use that temporary pause as proof that the problem remains under control.
The World Drug Report 2026 shows why that reasoning has become increasingly dangerous. The drug supply is changing too quickly to assume that tomorrow’s use will resemble yesterday’s. Potency can vary from one purchase to the next, and a familiar-looking pill or powder may contain an unfamiliar substance. At the same time, repeated use can worsen mental health, deepen dependence and cause consequences to accumulate long before a dramatic rock bottom arrives.
Early intervention is especially important for adolescents and young adults. The report notes that the adolescent brain is still developing and that early drug use can have lasting effects on behavior, emotion and cognition. It is also associated with poorer school performance, dropout and a greater likelihood of later substance use and psychiatric disorders.
Treatment Must Keep Pace With a Changing Drug Landscape
The central message of the World Drug Report 2026 is not that recovery has become less possible. It is that the conditions surrounding addiction are changing, and treatment systems must change with them.
Addiction treatment programs need to be prepared for potent synthetic opioids, stimulant addiction, polysubstance use, pharmaceutical misuse and co-occurring mental health conditions. They must also recognize that treatment cannot succeed when practical barriers make participation impossible. Clinical care, case management, medication when appropriate, peer connection, family support and thoughtful aftercare all have a role.
Detoxification or a short period of abstinence can address an immediate crisis, but recovery requires more. People need time and structure to understand why they use, recognize triggers, treat mental health symptoms, rebuild trust and develop a life that supports continued sobriety.
If you or someone you love is struggling with drugs or alcohol, contact Northstar Recovery Center to discuss your options and determine an appropriate next step.
